Home/Biossil/Anthony Mouchantaf

AM

Anthony Mouchantaf

Co-Lead (JD MBA)

Therapeutic Areas

Hematology Oncology Neurology Rare Diseases Pulmonology Nephrology Dermatology Women's Health

Biossil Pipeline

Drug	Indication	Phase
Undisclosed	Sickle Cell Disease	Phase 2/3

Leadership Team at Biossil

Alexander I. Mosa

Co-Lead (MD PhD)

View full Biossil profile